← Leaderboards
Roger L Shapiro
Harvard University (Sch Of Public Hlth)
$28,453,086
Attributed
$47,001,119
Total exposure
19
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.7M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$53,147,859 · 20
By mechanism
U01$26,927,452 · 4
R01$10,916,574 · 4
P01$10,634,136 · 9
D43$2,590,472 · 1
K24$1,448,499 · 1
K23$630,726 · 1
Top collaborators
- Daniel R Kuritzkes17 shared
- Mathias Lichterfeld17 shared
- Shahin Lockman16 shared
- Joseph Moeketsi Makhema9 shared
- Myron E Essex2 shared
- Rebecca Marie Zash1 shared
Most similar at Harvard University (Sch Of Public Hlth)
Same institution · by research overlap
- Marc J Lallemant$19,725,823
- Helen Suh Macintosh$6,099,140
Others in their field
Top investigators on “Botswana”
- Myron E Essex · Harvard University (Sch Of Public Hlth)$94,718,448
- Myron S Cohen · Family Health International$36,604,553
- Daniel R Kuritzkes · Brigham And Women'S Hospital$28,847,944
- Shahin Lockman · Harvard University D/B/A Harvard School Of Public Health$21,221,162
- Tendani Gaolathe · Botswana-Harvard Aids Institute$17,256,047
- Harvey Friedman · University Of Pennsylvania$14,384,854
Research focus
BotswanaInfantBirthSiteAdultClinical TrialsSafetyBaseProgramsAntiretroviral TherapyCohortAnti-Retroviral AgentsAfricaChildWomanPregnant WomenHiv-1PregnancyTreatment ProgramHiv InfectionsMonitorTreatment ProtocolsFundingReporting
Grant awards (90)
A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana$1,311,671
U01 · FY2025 · AI · contact PI
A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana$889,638
U01 · FY2025 · AI · contact PI
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV$762,247
P01 · FY2025 · HD · contact PI
Tsepamo Next Generation: Optimizing HIV Treatment and Prevention Strategies for Pregnant Women in Botswana$497,029
R01 · FY2025 · HD · contact PI
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV$431,126
P01 · FY2025 · HD · contact PI
Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens$420,142
P01 · FY2025 · HD · contact PI
Training in HIV Genomics, Treatment, and Cure Research in Botswana$302,400
D43 · FY2025 · TW
Administrative Core$223,047
P01 · FY2025 · HD · contact PI
Expansion of research and mentoring opportunities to reduce the burden of maternal and pediatric HIV in Botswana$183,538
K24 · FY2025 · AI · contact PI
Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens$130,202
P01 · FY2025 · HD · contact PI
Training in HIV Genomics, Treatment, and Cure Research in Botswana$100,000
D43 · FY2025 · TW · contact PI
Point-of-Care HIV Testing and Early Dolutegravir Use for Infants$50,013
P01 · FY2025 · HD · contact PI
Point-of-Care HIV Testing and Early Dolutegravir Use for Infants$10,984
P01 · FY2025 · HD · contact PI
A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana$2,095,803
U01 · FY2024 · AI · contact PI
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV$1,195,048
P01 · FY2024 · HD · contact PI
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana$951,356
U01 · FY2024 · AI · contact PI
Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens$614,198
P01 · FY2024 · HD · contact PI
Point-of-Care HIV Testing and Early Dolutegravir Use for Infants$204,065
P01 · FY2024 · HD · contact PI
Training in HIV Genomics, Treatment, and Cure Research in Botswana$202,400
D43 · FY2024 · TW · contact PI
Expansion of research and mentoring opportunities to reduce the burden of maternal and pediatric HIV in Botswana$184,611
K24 · FY2024 · AI · contact PI
Administrative Core$132,817
P01 · FY2024 · HD · contact PI
Training in HIV Genomics, Treatment, and Cure Research in Botswana$100,000
D43 · FY2024 · TW · contact PI
A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana$1,799,067
U01 · FY2023 · AI · contact PI
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV$1,202,581
P01 · FY2023 · HD · contact PI
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana$993,747
U01 · FY2023 · AI · contact PI
Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens$618,810
P01 · FY2023 · HD · contact PI
Training in HIV Genomics, Treatment, and Cure Research in Botswana$304,400
D43 · FY2023 · TW · contact PI
Point-of-Care HIV Testing and Early Dolutegravir Use for Infants$217,623
P01 · FY2023 · HD · contact PI
Expansion of research and mentoring opportunities to reduce the burden of maternal and pediatric HIV in Botswana$187,832
K24 · FY2023 · AI · contact PI
Administrative Core$173,815
P01 · FY2023 · HD · contact PI
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana$1,395,641
U01 · FY2022 · AI · contact PI
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV$1,214,934
P01 · FY2022 · HD · contact PI
Botswana Birth Outcomes Surveillance Extension$577,763
R01 · FY2022 · HD · contact PI
Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens$557,311
P01 · FY2022 · HD · contact PI
Training in HIV/AIDS Prevention and Treatment Research in Botswana$300,640
D43 · FY2022 · TW · contact PI
Point-of-Care HIV Testing and Early Dolutegravir Use for Infants$270,688
P01 · FY2022 · HD · contact PI
Administrative Core$193,279
P01 · FY2022 · HD · contact PI
Expansion of research and mentoring to improve birth outcomes and treatment outcomes among HIV-affected children in Botswana$176,401
K24 · FY2022 · AI · contact PI
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana$1,999,002
U01 · FY2021 · AI · contact PI
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV$1,340,804
P01 · FY2021 · HD · contact PI
Botswana Birth Outcomes Surveillance Extension$584,759
R01 · FY2021 · HD · contact PI
Training in HIV/AIDS Prevention and Treatment Research in Botswana$300,640
D43 · FY2021 · TW · contact PI
Administrative Core$223,468
P01 · FY2021 · HD · contact PI
Point-of-Care HIV Testing and Early Dolutegravir Use for Infants$223,467
P01 · FY2021 · HD · contact PI
Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens$223,467
P01 · FY2021 · HD · contact PI
Expansion of research and mentoring to improve birth outcomes and treatment outcomes among HIV-affected children in Botswana$178,153
K24 · FY2021 · AI · contact PI
Training in HIV/AIDS Prevention and Treatment Research in Botswana$78,072
D43 · FY2021 · TW · contact PI
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana$1,848,151
U01 · FY2020 · AI · contact PI
Botswana Birth Outcomes Surveillance Extension$604,783
R01 · FY2020 · HD · contact PI
Training in HIV/AIDS Prevention and Treatment Research in Botswana$300,640
D43 · FY2020 · TW · contact PI
Early Infant Treatment$249,815
U01 · FY2020 · AI · contact PI
Botswana Birth Outcomes Surveillance Extension$190,561
R01 · FY2020 · HD · contact PI
Expansion of research and mentoring to improve birth outcomes and treatment outcomes among HIV-affected children in Botswana$179,065
K24 · FY2020 · AI · contact PI
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana$2,158,015
U01 · FY2019 · AI · contact PI
Botswana Birth Outcomes Surveillance Extension$623,767
R01 · FY2019 · HD · contact PI
Training in HIV/AIDS Prevention and Treatment Research in Botswana$300,640
D43 · FY2019 · TW
Expansion of research and mentoring to improve birth outcomes and treatment outcomes among HIV-affected children in Botswana$179,078
K24 · FY2019 · AI · contact PI
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana$1,077,403
U01 · FY2018 · AI · contact PI
Early Infant Treatment$979,999
U01 · FY2018 · AI · contact PI
Botswana Birth Outcomes Surveillance Extension$667,378
R01 · FY2018 · HD · contact PI
Birth Outcomes Surveillance in Botswana$506,953
R01 · FY2018 · HD · contact PI
Training in HIV/AIDS Prevention and Treatment Research in Botswana$300,640
D43 · FY2018 · TW
Expansion of research and mentoring to improve birth outcomes and treatment outcomes among HIV-affected children in Botswana$179,821
K24 · FY2018 · AI · contact PI
Botswana Birth Outcomes Surveillance Extension$97,824
R01 · FY2018 · HD · contact PI
Early Infant Treatment$980,000
U01 · FY2017 · AI · contact PI
Birth Outcomes Surveillance in Botswana$518,115
R01 · FY2017 · HD · contact PI
Early Infant Treatment$979,999
U01 · FY2016 · AI · contact PI
Birth Outcomes Surveillance in Botswana$514,211
R01 · FY2016 · HD · contact PI
Early Infant Treatment$934,543
U01 · FY2015 · AI · contact PI
Birth Outcomes Surveillance in Botswana$509,154
R01 · FY2015 · HD · contact PI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$348,090
R01 · FY2015 · HD · contact PI
Early Infant Treatment$979,999
U01 · FY2014 · AI · contact PI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$688,133
R01 · FY2014 · HD · contact PI
Birth Outcomes Surveillance in Botswana$510,574
R01 · FY2014 · HD · contact PI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$885,020
R01 · FY2013 · HD · contact PI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$1,009,257
R01 · FY2012 · HD · contact PI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$938,095
R01 · FY2011 · HD · contact PI
HAART to Prevent HIV Transmission to Infants In Botswana$866,664
U01 · FY2010 · AI · contact PI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$513,609
R01 · FY2010 · HD · contact PI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$131,499
R01 · FY2010 · HD · contact PI
HAART to Prevent HIV Transmission to Infants In Botswana$862,925
U01 · FY2009 · AI · contact PI
HAART to Prevent HIV Transmission to Infants In Botswana$1,371,298
U01 · FY2008 · AI · contact PI
HAART to Prevent HIV Transmission to Infants In Botswana$857,739
U01 · FY2007 · AI · contact PI
HAART to Prevent HIV Transmission to Infants In Botswana$1,003,564
U01 · FY2006 · AI · contact PI
HAART to Prevent HIV Transmission to Infants In Botswana$341,413
U01 · FY2005 · AI
DIARRHEAL DISEASE STUDY$120,338
K23 · FY2004 · HD
DIARRHEAL DISEASE STUDY$119,852
K23 · FY2003 · HD
DIARRHEAL DISEASE STUDY$131,066
K23 · FY2002 · HD
DIARRHEAL DISEASE STUDY$130,167
K23 · FY2001 · HD
DIARRHEAL DISEASE STUDY$129,303
K23 · FY2000 · HD